Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Other Non-current Assets
Long-term assets not reported separately.
Sionna Therapeutics, Inc.NASDAQ: SION
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets rises 60.9% from a year ago
Other non-current assets stood at $1.55M at the end of Q1 FY2026, up 60.9% from a year earlier and up 60.7% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.
Context
- Other non-current assets amounted to 0.5% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +60.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 963K USD
- Year-over-year change
- -75.7%
- 3-year CAGR
- +0.0%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 963K | -75.7% |
| FY2024 | 2024-12-31 | 3.96M | +8890.9% |
| FY2023 | 2023-12-31 | 44K | -95.4% |
| FY2022 | 2022-12-31 | 962K | — |
Other Non-current Assets vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 other non-current assets of $1.55M is the 10th highest of the 11 companies compared; the peer median is $8.43M.
- Its year-over-year change of +60.9% is the 4th highest of 11, against a peer median of +29.0%.
- Other non-current assets amounts to 0.5% of total assets for SION, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $116.2M | +26.1% | +63.0% | 23.0% | |
| Sep 2026 | $63.62M | +19.9% | +8.2% | 4.2% | |
| Jun 2026 | $39.3M | +1226.4% | +163.6% | 10.6% | |
| Sep 2026 | $27.24M | +268.8% | — | 2.3% | |
| Sep 2026 | $9.69M | +3.4% | +404.5% | 1.3% | |
| Sep 2026 | $7.18M | +50.7% | +119.8% | 1.4% | |
| Mar 2026 | $5.41M | +66.6% | +44.5% | 1.3% | |
| Mar 2026 | $4.76M | +31.9% | +23.3% | 0.5% | |
| Jun 2026 | $3.8M | +7.1% | +105.1% | 0.7% | |
| Mar 2026 | $1.55M | +60.9% | +0.0% | 0.5% | |
| Mar 2026 | $1.1M | +12.9% | +3.3% | 0.3% | |
| Peer median (excluding SION) | $8.43M | +29.0% | +63.0% | 1.4% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.